Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Rybelsus. Rybelsus is an oral form of semaglutide. It’s FDA-approved for diabetes, but (like Ozempic) it’s sometimes prescribed off-label for weight loss. Compounded semaglutide. Compounded ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

A decision is expected in the fourth quarter of 2025.

Rybelsus. Rybelsus is a daily pill FDA-approved for diabetes but sometimes prescribed off-label for weight loss. As with brand-name versions of semaglutide, there’s no magic number for how long ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...